Stock market week-in-review for 5 large GI companies — Aug. 7-11

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 7 to Aug. 11, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $242.55 on Aug. 7
Peaked: $245.23 on Aug. 8
Closed: $232.88 on Aug. 11
Percent change between Aug 7 to Aug. 11: -3.98 percent

2. Exact Sciences Corp.

Opened: $38.69 on Aug. 7
Peaked: $39.75 on Aug. 7
Closed: $37.76 on Aug. 11
Percent change between Aug 7 to Aug. 11: -2.40 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 7
Peaked: $134.41 on Aug. 11
Closed: $133.27 on Aug. 11
Percent change between Aug 7 to Aug. 11: 0.12 percent

4. Synergy Pharmaceuticals

Opened: $3.73 on Aug. 7
Peaked: $3.86 on Aug. 8
Closed: $2.96 on Aug. 11
Percent change between Aug 7 to Aug. 11: -20.64 percent

5. Valeant Pharmaceuticals

Opened: $15.09 on Aug. 7
Peaked: $16.89 on Aug. 8
Closed: $13.87 on Aug. 11
Percent change between Aug 7 to Aug. 11: -8.08 percent

More articles on gastroenterology: 
GI center to know: GastroIntestinal Health
Stock market week-in-review for 4 large ASC chains — Aug. 7-11
GI leader to know: Dr. Neil Price of GastroIntestinal Health

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.